Brief communication: attitudes and preferences of long-acting injectable HIV preexposure prophylaxis among Thai adolescents and young adults

被引：0
|
作者：
Wongsethanatada, Alisa [1 ]
Songtaweesin, Wipaporn Natalie [2 ,3 ]
Wongharn, Prissana [3 ]
Moonwong, Juthamanee [3 ]
Khamthi, Sasiprapha [3 ]
Pitikawinwong, Lucksanapon [3 ]
Puthanakit, Thanyawee [3 ,4 ,5 ]
机构：
[1] Chulalongkorn Univ, Fac Med, Bangkok, Thailand
[2] Chulalongkorn Univ, Fac Med, Sch Global Hlth, Bangkok, Thailand
[3] Ctr Excellence Pediat Infect Dis & Vaccines, Bangkok, Thailand
[4] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand
[5] Chulalongkorn Univ, Fac Med, Dept Pediat, Div Infect Dis, Bangkok, Thailand
来源：
AIDS RESEARCH AND THERAPY | 2025年 / 22卷 / 01期
关键词：
HIV; PrEP; Long-acting; Youth; Adolescents; Men who have sex with men; Preference; CABOTEGRAVIR; PREVENTION;
D O I：
10.1186/s12981-025-00721-z
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
This study aimed to explore willingness to use and preference for long-acting injectable PrEP (LAI-PrEP) among Thai youth at risk of HIV. A cross-sectional study was conducted in 100 Thai youth aged 18 to 24 years attending a sexual health clinic in Bangkok, Thailand. Participants received information about oral and LAI-PrEP before completing a questionnaire. Of the 98 participants willing to use pre-exposure prophylaxis, 47 preferred the injectable form. Preference for the injectable form was higher among individuals not currently using oral pre-exposure prophylaxis, affordability and longer injection intervals were key for acceptance of long-acting injectable pre-exposure prophylaxis.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Pharmacokinetics of Injectable, Long-Acting Nevirapine for HIV Prophylaxis in Breastfeeding Infants
    Cortez, John M., Jr.
    Quintero, Rafaela
    Moss, John A.
    Beliveau, Martin
    Smith, Thomas J.
    Baum, Marc M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 59 - 66
  • [22] Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa
    Ogunbajo, Adedotun
    Tsai, Alexander C.
    Kanki, Phyllis J.
    Mayer, Kenneth H.
    AIDS AND BEHAVIOR, 2022, 26 (07) : 2363 - 2375
  • [23] Transforming HIV prevention: the promise of long-acting preexposure prophylaxis in high HIV burden settings
    Davey, Dvora Joseph
    Dadan, Sumaya
    Wara, Nafisa
    CURRENT OPINION IN HIV AND AIDS, 2025, 20 (01) : 32 - 38
  • [24] Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model
    Maloney, Kevin M.
    Le Guillou, Adrien
    Driggers, Robert A.
    Sarkar, Supriya
    Anderson, Emeli J.
    Malik, Amyn A.
    Jenness, Samuel M.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01) : 72 - 82
  • [25] "WHAT IS THE BENEFIT?": PERCEPTIONS AND PREFERENCES FOR LONG-ACTING INJECTABLE ANTIRETROVIRAL THERAPY AMONG PEOPLE LIVING WITH HIV
    Rodriguez, Humberto Gonzalez
    Volcan, Andrea Isabel
    Castonguay, Breana Jae Uhrig
    Carda-Auten, Jessica
    Ruiz, Carolina
    Peretti, Matteo
    Suarez, Angela
    Kerrigan, Deanna
    Wohl, David Alain
    Barrington, Clare
    AIDS EDUCATION AND PREVENTION, 2023, 35 (06) : 467 - 483
  • [26] Variation in Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among US Men Who Have Sex with Men: A Latent Class Analysis
    Beckham, S. Wilson
    Sanchez, Travis
    Fowler, Rebecca
    Zlotorzynska, Maria
    Rai, Mona
    Sullivan, Patrick
    Vannappagari, Vani
    Sarkar, Supriya
    Glick, Jennifer L.
    Rinehart, Alex R.
    Rawlings, Keith
    Bridges, John F. P.
    AIDS PATIENT CARE AND STDS, 2023, 37 (10) : 495 - 503
  • [27] The Invisible Product: Preferences for Sustained-Release, Long-Acting Pre-exposure Prophylaxis to HIV Among South African Youth
    Montgomery, Elizabeth T.
    Atujuna, Millicent
    Krogstad, Emily
    Hartmann, Miriam
    Ndwayana, Sheily
    O'Rourke, Shannon
    Bekker, Linda-Gail
    van der Straten, Ariane
    Minnis, Alexandra M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 80 (05) : 542 - 550
  • [28] Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
    Atuhaire, Bridget
    Muteebwa, Laban
    Nabunya, Racheal
    Muhindo, Richard
    Ngabirano, Tom Denis
    Osingada, Charles Peter
    Muwanguzi, Patience A.
    AIDS RESEARCH AND THERAPY, 2024, 21 (01):
  • [29] Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection
    Dandachi, Dima
    Dang, Bich N.
    Lucari, Brandon
    Swindells, Susan
    Giordano, Thomas P.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2021, 33 (06): : 801 - 809
  • [30] Brief Report: Interest in Long-acting Injectable PrEP Among Transgender Women in Eastern and Southern United States
    Cooney, Erin E.
    Reisner, Sari L.
    Poteat, Tonia C.
    Althoff, Keri N.
    Radix, Asa
    Stevenson, Meg
    Wawrzyniak, Andrew J.
    Cannon, Christopher
    Schneider, Jason S.
    Mayer, Kenneth H.
    Beyrer, Chris
    Brown, Carolyn A.
    Vannappagari, Vani
    de Ruiter, Annemiek
    Ragone, Leigh
    Wirtz, Andrea L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 97 (01) : 19 - 25
12345